The National Comprehensive Cancer Network® (NCCN®) in the USA is publishing new results for its latest survey on cancer drug shortages in the...
Vous n'êtes pas connecté
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National Comprehensive Cancer Network survey.Following data published one year ago and six...
The National Comprehensive Cancer Network® (NCCN®) in the USA is publishing new results for its latest survey on cancer drug shortages in the...
Cross-border tumour boards of cancer specialists from different European countries meeting virtually to review the management of individual patients...
Nearly 53 percent people with Attention Deficit Hyperactivity Disorder (ADHD) remain silent about their diagnosis. Almost 66 percent of young women...
DelveInsight’s, “Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies...
DelveInsight’s, “Peritoneal Cancer Pipeline Insight 2024” report provides comprehensive insights about 55+ companies...
FRIDAY, June 21, 2024 -- The rate of firearm injury emergency medical services (EMS) encounters increased from 2019 to 2020 and remained elevated...
FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...
FRIDAY, June 28, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in...
FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...